Timeline

2015

1ªs Certificações

Primeiras certificações GMP e GDP suíça e
europeia, para os extratos de Cannabis,
incluindo o CBD.

2016

Validação de Métodos e Processos

2017

CPhI

Apresentação do óleo CBD Isolado, durante
o maior evento farmacêutico mundial, a CPhI,
em Frankfurt, Alemanha.

2017

Pipeline do TCH

Autorização da SWISSMedic para
desenvolvimento de extratos à base de
Cannabis, ricos em THC.

2019
cbd

Promediol® CBD

Promediol® CBD é lançado
na Europa e na Suíça.

2020
cbd

Promediol® CBD FULL Spectrum

Promediol® CBD FULL Spectrum é lançado

na Suíça e no Brasil.

ANNOUCEMENTS

PROMEDIOL DO BRASIL announces the licensing of the product CANNABIS SATIVA PROMEDIOL
EXTRACT – 50mg/mL, 10 mL and 30mL bottles, our first product authorized by ANVISA, for the
national pharmaceutical company BIOLAB SANUS.

To all who contributed to make this important achievement possible, our sincere thanks.

Adriana Schulz dos Santos

General Director on June 6, 2022

We comply with all relevant pharmaceutical standards and European Good Practices guidelines.

Our products are certified by Swissmedic (Swiss Agency for Therapeutic Products) and
recognized by E.M.A. (European Medicines Agency)

Good Manufacturing Practices

Good Agricultural Practices

Good Distribution Practices

Worldwide shipment

✓ International delivery
✓ Tracking service
✓ Advanced logistic
✓ Climatized temperature
✓ Electronic monitoring

Totally monitored, from order to delivery.